Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells

There has recently been a paradigm shift in the field of dendritic cell (DC)-based immunotherapy, where several clinical studies have confirmed the feasibility and advantageousness of using directly isolated human blood-derived DCs over in vitro differentiated subsets. There are two major DC subsets...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Immunol Immunother
Autors principals: Sköld, Annette E., Mathan, Till S. M., van Beek, Jasper J. P., Flórez-Grau, Georgina, van den Beukel, Michelle D., Sittig, Simone P., Wimmers, Florian, Bakdash, Ghaith, Schreibelt, Gerty, de Vries, I. Jolanda M.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6132867/
https://ncbi.nlm.nih.gov/pubmed/30019146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-2204-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars